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1. Introduction  
Currently, cardiovascular diseases (CVD) are one of the most important problems in the 
world. In fact, CVD are the first cause of death all over the world and, according to the 
World Health Organization (WHO), it is expected to remain so over coming years due to 
aging population and the increase of prevalence of CVD in countries with fewer resources.  
According to European statistics, 2008 for CVD, the leading causes of death in Europe are 
coronary heart disease and stroke. In Europe, deaths from these diseases are 4.3 million each 
year. Nearly half (48%) of all deaths are due to CVD (54% of deaths in women and 43% of 
deaths in men). Regional variations in cardiovascular mortality have been observed both 
between and within countries in Europe (Sans et al., 1997; Müller et al., 2004). Coronary 
heart disease mortality patterns showed a clear north–east to south–west gradient in CVD 
mortality (1990–1992; 45–74 years age-adjusted) with the lowest rates for both men and 
women in France, Spain, Switzerland, and Italy (Sans et al., 1997). Many factors could be 
related to the different distribution (eating behaviours, life style, and genetics). 
To begin with the development of this chapter it is necessary to consider firstly the health 
determinants to better understand and focus the aim of this chapter.  
The model of health fields proposed by Laframboise in 1973 and developed in Lalonde 
Report in 1974 (Lalonde 1974) has revolutionized contemporary public health due to the 
approaching and explaining of the health levels in the populations and therefore, the way of 
formulating health policies. Marc Lalonde proposed a new "health field" concept that can be 
broken up into four broad elements: Human biology, Environment, Lifestyle, and Health 
Care Organization". 
Of the four determinants of health, the one which is most susceptible to be modified is 
lifestyle. Apart from not smoking, the most important lifestyle determinants of good health 
are what we eat and how active we are. A healthy diet helps to maintain or improve our 
health. However, as we said before, the CVD are increasing all over the word, and 
authorities view it as one of the most serious Public Health problems in the 21st century.  
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CVD are complex and the risk factors that contribute to the development of CVD can be 
classified into different categories depending on whether they are modified or not (Posner et 
al., 1991, Haskell et al., 2003) and how they contribute to the development of CVD (Linton et 
al., 2003). Thus, on the one hand, we have not modifiable factors such as age, sex, family 
history and genetics. With regard to genetics, we inherit the genetic risk to develop CVD, 
but this risk can be modulated by other modifiable factors. In this chapter we will deeply 
discuss the relation between genes and environmental factors (especially diet) in the 
prevention of CVD (Figure 1). 
On the other hand, we also have factors that are susceptible to be modified such as cholesterol 
concentrations, hypertension, smoking, diabetes, type of diet, obesity, sedentary lifestyle, 
stress and consumption of oral contraceptives. The more risk factors a person has, the higher 
risk of developing CVD. Some risk factors can be changed, treated or modified, and some 
others not. But controlling the largest possible number of risk factors through changes in 
lifestyle and/or drugs can reduce cardiovascular risk. Among the environmental factors 
associated with CVD, and as a part of one of the health determinants proposed by Lalonde, 
diet has a great impact on lipid metabolism, oxidative stress and the development of the 
atherosclerotic process (Ordovas et al., 2004) (Figure 1). Changes in eating behaviours have 
contributed to the growing epidemic of chronic diseases. These changes are characterized by 
an unbalanced diet consisting of food with a high density of energy rich in saturated fatty 
acids (SAF) as well as a decrease in physical activity. This process is called nutritional 
transition. Given these facts, researchers are trying to elucidate the best diet to prevent CVD. 
However, there is a widespread of controversy. Different proposals have been considered such 
as low-fat diet, diet low in carbohydrates and high in proteins, among others, all promoted by 
the acquisition of knowledge, fashion or business interests (Ordovas et al., 2004). 
Traditionally, the American Heart Association (AHA) has based dietary recommendations for 
primary care of cardiovascular risk in a low-fat diet (Krauss MR et al, 2000). This diet is also 
based on reducing all types of fat so that the contribution of total fat calories should be less 
than 30% (of which SAF are less than 10%) and cholesterol intake less than 300 mg daily. This 
type of diet causes a decrease in total cholesterol (TC) and LDL-C, and a decrease or not 
variation in HDL-C and increases or unchanged triglycerides (TG) concentrations (Obarzanek 
et al., 2001; Lichtensein et al., 2002, Howard et al., 2006). Later on, in 2005, a new version of 
USDA pyramid in which food groups are presented in vertical and which incorporates the 
concept that the diet should be tailored to individual needs came up (USDA, 2005). 
After the AHA recommendations, other types of diets have been proposed such as diets rich 
in protein, low carb, Mediterranean diet, etc. Mediterranean diet has attracted the most 
interest by its great relevance regarding the protective role in primary and secondary care of 
CVD.  
The aim of this chapter is to analyse the role of the Mediterranean diet in determining 
intermediate CVD phenotypes. We also review one of the most emerging topics currently: 
the role of gene-Mediterranean diet interactions on CVD. 
2. Mediterranean diet  
Due to the great incidence of CVD, Mediterranean diet has gained a considerable popularity 
during the last decades. The Mediterranean area is a sociocultural construction built on the 
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countries bordering the Mediterranean Sea. Food habits have been consolidated over the 
centuries and are the result of geographical and climatic factors, as well as cultural, political 
and religious factors of Mediterranean people. Mediterranean area is identified by 
characteristics based on agriculture (natural grain, olives, wine and vegetables), fishing and 
consumption of poultry instead of other meats. 
Furthermore, Mediterranean diet includes food and cooking techniques typical of 
Mediterranean countries which have been gradually abandoned by western patterns.  
The Mediterranean diet has been described as a model from a nutritional point of view due 
to the good balance that provides its food items (micronutrients, vitamins, antioxidants). 
Nevertheless, as well as the cooking techniques have been abandoned, in the last few years 
changes in lifestyle have triggered a move away from the recommended intakes in relation 
to several nutrients. All these changes make it even more difficult to ensure adequate 
intakes of vitamins and minerals. This problem could affect more to certain risk groups such 
us women, the elderly, children, gestating and lactating women and ill people. Knowing the 
extent of this reality it seems worthy to inform people and society in general about the 
necessary changes in the diet and about the characteristics of the Mediterranean diet which 
are being lost and should be restored. 
2.1 Definition of the Mediterranean diet 
The concept of the Mediterranean diet originated from several observational studies in the 
1950s, being the most known the Seven Countries Study initiated by Ancel Keys (Ancel 
Keys 1970). Subsequently, several studies have associated increased longevity, lower 
mortality and morbidity to Mediterranean diet (Keys et al., 1986; de Lorgeril et al., 1999; 
Singh et al., 2002; Trichopoulou et al., 2003; Knoops et al., 2004). Taken as a whole, these 
studies showed that, despite a high fat intake, these populations had low rates of coronary 
heart disease and other vascular diseases, cancer, inflammatory and degenerative diseases, 
resulting in a long life expectancy. The Mediterranean dietary pattern was considered to be 
largely responsible for the good health observed in these regions (Keys et al., 1986). 
Currently, there is a great number of clinical and epidemiological studies that have shown 
the benefits of the Mediterranean diet. However, these effects are attributed to the 
traditional Mediterranean diet and not to the Westernized patterns that nowadays 
characterize the South European countries (Serra-Majem et al., 2004).  
Although there are several variations of the Mediterranean diet, the main characteristics 
include high consumption (daily consumption) of vegetables, fruit, whole grain cereals and 
low fat dairy products; weekly consumption of fish, poultry, tree nuts and legumes; 
relatively low consumption of red meat (approximately twice a month) as well as moderate 
daily consumption of alcohol (preferably in the form of wine) normally with meals (keys et 
al., 1986) (Figure 1).  
Most of the articles published so far on Mediterranean diet are observational studies. 
However, there is a lack of intervention studies that demonstrate causal relationship. 
Although there are few randomized controlled trials of dietary intervention with 
Mediterranean Diet, we have recently strong data from one large randomize control trial 
supporting the beneficial effects of Mediterranean diet on CVD prevention (Estruch et al., 
2006). 
www.intechopen.com
 
 Recent Advances in Cardiovascular Risk Factors 
 
492 
2.2 Principal studies that focus on Mediterranean diet and cardiovascular diseases  
In general, there is a predominance of observational studies related to Mediterranean Diet 
compared to clinical trials in the study of CVD. Thus, most of the studies are cross-sectional 
studies with a level III of evidence (based on the quality of evidence according to the 2nd 
edition of the U.S. Task Force (Harris et al., 2001)). The ATTICA study is the most 
remarkable (Pitsavos et al., 2003) and it was conducted on a representative sample of Greek 
men and women recruited from May 2001 to December 2002 in order to analyze 
cardiovascular risk factors, establish associations with lifestyle, socioeconomic factors, 
psychological characteristics, and assess their impact on CVD over a year, five and ten years. 
Several studies found a positive association between Mediterranean Diet and CVD (Tzima 
et al., 2007; Panagiotakos et al., 2006; Pitsavos et al., 2007). 
Two other large European cohort studies (evidence level II-2) include the Greek cohort 
within EPIC (European Prospective Investigation into Cancer) (Trichopoulou et al., 2003, 
Slimani et al., 2002). They study the relationship between nutrition and cancer in 519,978 
participants from 23 centers located in 20 European countries.  
Another cohort study is the HALE (Knoops et al., 2004) (Healthy Ageing: Longitudinal 
Study in Europe). This project analyzed age-related changes and the determinants of healthy 
aging in terms of mortality and morbidity, and physical, mental, cognitive and social 
functionality in 13 European countries. Results from this study suggest that a high 
adherence to Mediterranean diet is associated with a reduction in both overall mortality and 
cardiovascular mortality. 
Regarding intervention studies (level I of scientific evidence), two of the most known 
studies analyzing Mediterranean Diet are PREDIMED study (Prevention with 
Mediterranean diet) (Estruch et al., 2006) and Medi-RIVAGE study (Mediterranean Diet, 
Cardiovascular Risks and Gene Polymorphism) (Vincent-Baudry et al., 2005). 
PREDIMED study is a multicenter, prospective, randomized, controlled trial whose goals 
are to assess the efficacy and safety of a Mediterranean diet in primary care of CVD. It was 
designed in 2002 and it is the first long-term clinical trial that recruits high-risk patients 
(around 7,000 participants from different regions in Spain) to follow a Mediterranean diet 
supplemented with virgin olive oil (VOO) (1 liter a week) or nuts (30 g per day of which 15 
g almonds and 15 g walnuts). 
Medi-RIVAGE study is a randomized clinical trial conducted in France on 212 women and 
men with at least one cardiovascular risk factor. The aims of the study are to evaluate the 
effect of two types of diet in the prevention of CVD and to investigate biological 
mechanisms and genetic polymorphisms related to metabolism. On the one hand, they 
study the traditional Mediterranean diet (35-38% of total energy from fat: 50% 
monounsaturated fatty acids (MUFA), 25% polyunsaturated fatty acids (PUFA), 25% SFA) 
and on the other hand, a low fat diet based on the AHA (30% of total energy from fat: 33% 
MUFA, 33% PUFA, 33% SFA). 
With regard to studies that analyze final cardiovascular risk phenotypes, two of the most 
outstanding studies (level I of scientific evidence) are the Lyon Diet Heart Study and the 
Indio-Mediterranean Diet Heart study. 
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The Lyon Diet Heart Study (de Lorgeril et al., 1999), a randomized, controlled trial with free-
living subjects (half of 600 men and women in France), tested the effectiveness of a 
Mediterranean-type diet (consistent with the new AHA Dietary Guidelines) on composite 
measures of the coronary recurrence rate after a first myocardial infarction during 46 
months. Subjects in the experimental group were instructed by cardiologists and dietitians 
to adopt a Mediterranean-type diet. They demonstrated the effectiveness of Mediterranean 
diet in the secondary care of CVD. However, the intervention group with Mediterranean 
diet received margarine rich in alpha-linolenic fatty acid, fact that distorted the 
interpretation of results, as margarine is not a component of traditional Mediterranean diet. 
Something similar happens with the Indo-Mediterranean Diet Heart Study (Singh et al., 
2002).  
The Indo Mediterranean Diet Heart study is a randomized, single-blind trial in 1000 patients 
with angina pectoris, myocardial infarction, or surrogate risk factors for CVD. 499 patients 
were allocated to a diet rich in whole grains, fruits, vegetables, walnuts, and almonds. 501 
controls consumed a local diet similar to the step I National Cholesterol Education Program 
(NCEP) prudent diet. They showed that an Indo-Mediterranean diet, that is rich in a-
linolenic acid, might be more effective in primary and secondary prevention of CVD than 
the conventional step I NCEP prudent diet. However, as in the Lyon Diet Heart Study, the 
intervention group with Mediterranean diet increased the consumption of alpha-linolenic 
fatty acid from soybean and mustard oil, which are not typical from Mediterranean 
countries. 
3. Mediterranean diet in determining intermediate cardiovascular disease 
phenotypes 
There is a great number of studies analysing the effect of the consumption or adherence to 
Mediterranean diet and intermediate CVD phenotypes. In the following sections we review 
the studies analysing Mediterranean diet and obesity, lipid metabolism, glucose 
concentrations, blood pressure and inflammation. Table 1 shows the effect of Mediterranean 
diet on the aforementioned phenotypes. 
3.1 Mediterranean diet and obesity 
Currently, it is not known which is the best diet is to lose weight (low-carb, high protein, 
low fat diet, etc.). Consumption of nuts, and high fat diets (rich in MUFA), characteristics of 
the Mediterranean diet, have been traditionally associated with an increased body weight by 
its high contain in fats. However, recent scientific evidence does not support these data. 
Adherence to Mediterranean diet was inversely associated with BMI and obesity in a cross-
sectional survey carried out in the northeast of Spain (Schröder et al., 2004). Obesity risk 
decreased in both men and women with increasing adherence to the traditional 
Mediterranean diet.  
Results from epidemiological studies on large populations indicate that subjects who 
usually consume nuts have lower BMI than those who do not consume (Bes-Rastrollo  et al, 
2009, Garcia-Lorda et al, 2003; Schroder et al, 2004). In addition, the SUN cohort 
(Seguimiento Universidad de Navarra) (follow-up University of Navarra) evaluated 11,895 
participants and found an inverse association between consumption of nuts and weight gain 
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per year (Martinez-Gonzalez & Bes-Ballostro, 2011). Similarly, a recent study carried out in 
EPIC-PANACEA project showed that individuals with high adherence to Mediterranean 
diet, according to the score based on a questionnaire of adherence to Mediterranean diet (11-
18 points), showed in a weight change of 20.16 kg (95% CI :20,2-20, 7 kg) 5 years and they 
were also 10% less likely to become overweight and obese compared with individuals with 
lower adherence (0-6 points) (Romaguera et al., 2010). Furthermore, a study that evaluated 
497,308 individuals aged between 25-70 years in 10 European countries found that high 
adherence to the Mediterranean diet is associated with lower abdominal adiposity, using 
waist circumference as a measure (Romaguera et al., 2009). 
With respect to intervention studies, it has been shown that subjects that consume daily tree 
nuts in their diet are less likely to gain weight (Li et al., 2010). A study evaluating the intake 
of almonds (42-72 g daily) in 81 patients over 6 months found that there was no significant 
weight gain (Fraser et al., 2002). Similarly, García-Londa et al, (2003) found that in the short 
term, the addition of tree nuts to diet, in amounts up to 50 g daily, does not increase weight. 
After one year of intervention in the PREDIMED study, beneficial effects on waist 
circumference were shown (Martinez-Gonzalez & Bes-Ballostro, 2011).  
Finally, a meta-analysis regarding Mediterranean diet and weight loss analyzing randomize 
controlled trials has been recently published (Esposito et al., 2011), and it concludes that 
Mediterranean diet does not cause weight gain, which removes the objection to its relatively 
high fat content. Mediterranean diet could be a strategy to help people lose weight.  
Some of the proposed mechanisms that might explain these facts are that the absorption of 
nuts may be incomplete, thus some of its fat content may not be absorbed by the body and 
would be excreted in the feces. Moreover, the consumption of nuts may have a satiating 
effect, producing a decrease in consumption of other foods and helping to control total 
energy intake. Although it still has not been proved, there may be an adaptation of the 
metabolism, so that energy consumption could be more efficient and get the body burn 
more energy, thus avoiding an accumulation of body fat (Brennan et al., 2010; Garcia-Lorda 
et al., 2003; Rajaram & Sabaté, 2006).  
3.2 Mediterranean diet and lipid metabolism  
Mediterranean diet has been largely studied in relation to lipid metabolism because of its 
beneficial effect on CVD. However, different results have been shown regarding a variety of 
studies, designs, and sample sizes. Cross-sectional studies with similar characteristics, with 
a sample size between 1762 and 2032 participants in Greece (ATTICA study), evaluated the 
adherence to Mediterranean diet and lipid profile. Thus, Tzima et al (2007) reported that 
subjects who are overweight (BMI 25-29.9) or obese (BMI ≥ 30) in the highest tertile of the 
Mediterranean diet score had lower total cholesterol (TC) (-13 %, P = 0.001) after adjusting 
for age, sex and BMI compared to the first tertile. However, there were no significant 
differences in triglycerides (TG) and HDL-C. This increase in the adherence to 
Mediterranean diet was also associated with lower total cholesterol (p <0.001) in a study 
carried out by Panagiotakos et al (2006). In addition to that, individuals with abdominal 
obesity and less physically active had lower adherence to Mediterranean diet (p = 0.008) 
with lower HDL-C (p <0.05) (Pitsavos et al., 2007). 
www.intechopen.com
Mediterranean Diet and Gene-Mediterranean Diet 
Interactions in Determining Intermediate Cardiovascular Disease Phenotypes 
 
495 
Moreover, seven studies of 29 clinical trials with 3,822 subjects (2,202 assigned to 
Mediterranean diet and 1,903 assigned to a control diet) reported beneficial effects of 
adherence to Mediterranean diet on HDL-C (Papadaki & Scott, 2008; Esposito et al., 2004; 
Estruch et al., 2006; Esposito et al., 2003; Esposito et al., 2009; Athryros et al., 2011). A recent 
meta-analysis (Kastorini et al., 2011) showed that, overall, adherence to Mediterranean diet 
was associated with higher HDL-C levels as compared with a control diet.  
Benefits in TC have also been shown in some randomized controlled trials (Estruch et al., 
2006; Vincent-Baudry et al., 2005; Ambring et al., 2004). In this sense, Estruch et al., (2006) 
carried out a study of 3 months with individuals who had diabetes mellitus or one or more 
cardiovascular risk factors, which were assigned to three intervention groups (n = 257-8 / 
group) (2 Mediterranean diet (one supplemented with VOO and another one with 15g of 
almonds+15g walnuts/day) and one control diet low in fats). Regarding the lipid profile, 
both Mediterranean diets showed significant increase in HDL-C levels (p = <0.001 and p = 
0.006, respectively) and a significant reduction (p <0.001 and p = 0.002, respectively) in the 
atherogenic index (TC/HDL-C) in contrast to the control group. However, only 
Mediterranean diet supplemented with nuts showed a significantly reduction in TC (p = 
0.040) and TG (p = 0.022), compared to control. Neither of the Mediterranean diets 
significantly reduced LDL-C compared to the control diet (low fat diet). 
Concerning TG, three observational studies reported a beneficial effect of Mediterranean 
diet (Chrysohoou et al., 2004; Tzima et al., 2007; Barzi et al., 2003) as compared with low 
adherence to Mediterrenean diet. Five interventional studies showed beneficial effects of 
Mediterranean diet on TG concentrations (Shai et al., 2008; Esposito et al., 2004; Estruch et 
al., 2006; Esposito et al., 2009; Elhayany et al., 2011), whereas other studies did not find 
significant differences (de Lorgeril et al., 1994; Castro et al., 2000; Michalsen et al., 2006).  
Moreover, results from a crossover study during 4 weeks for each intervention (22 healthy 
people (12H/10M)) found an improvement in lipid profile to compare a Mediterranean diet 
(rich in omega 3) with a Swedish standard diet (Ambring et al., 2004). The results showed a 
significant decrease in TC, LDL-C, TG (17%, 22%, and 17%) in the group with 
Mediterranean diet. On the other hand, one non-randomize control trial carried out in Italy 
(47 obese women) during 4-month with an hypoenergetic Mediterranean diet together with 
a program of physical exercise showed a significant decrease in total cholesterol and TG 
concentrations. Levels of LDL-C decreased (p <0.001) after 4 months of intervention, 
whereas HDL-C increased (Andreoli et al., 2008). However, another study carried out in 71 
healthy Canadian found a significant decrease in TC at 6 weeks of intervention (p <0.05), 
whereas no significant changes were observed after 12 weeks. Levels of HDL-C, LDL-C and 
TG were not affected after 6 or 12 weeks of intervention (Goulet et al., 2003). Different 
characteristics of the recruitment of individuals can influence the final results of the studies. 
The relationship between nut consumption and reduced risk of CVD has been established in 
numerous epidemiological studies. Thus, Ros et al (2004), in a crossover study carried out in 
hypercholesterolemia subjects in Spain, determined whether a diet containing nuts (18% of 
energy) could improve markers related to endothelial function against another typical 
Mediterranean diet with similar energy intake, fat, protein, carbohydrates, but not MUFA 
intake, after 4 weeks. Estruch et al (2006) also found a significant decrease in TC (p = 0.017) 
and LDL-C (p = 0.010). However, no differences were found in TG concentrations and HDL-
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C. Pooled analysis in 25 clinical trials to evaluate nut consumption in blood lipids showed 
that the most important finding is that the cholesterol-lowering effects of nut consumption 
are dose related and are more pronounced in subjects with higher baseline LDL-C or lower 
BMI. Nut consumption also lowered TG levels in subjects with hypertriglyceridemia (Sabate 
et al., 2010). 
3.3 Mediterranean diet and glucose concentrations 
The increasing incidence of type 2 diabetes throughout the world is also linked to 
westernized dietary patterns. Lifestyle changes are effective measures to prevent diabetes. 
The Mediterranean diet has also shown beneficial effects on diabetes risk and glucose 
concentrations.  
Two observational studies reported a beneficial effect of close adherence to Mediterranean 
diet as compared with a control diet in lowering fasting glucose (FG) levels (Tzima et al., 
2007; Panagiotakos et al., 2007).  
Furthermore, Estruch et al., 2006  found that participants in the intervention group with 
Mediterranean diet supplemented with VOO or nuts, showed a significant reduction in FG 
compared with the control group (-0.39 mmol / L and -0.30 mmol / L, respectively). 
In this sense, in another randomized controlled trial (Vincent-Baudry et al., 2005) with 
Mediterranean diet or low-fat diet, after 3 months of intervention, both diets significantly 
reduced blood glucose, insulinemia, insulin resistance and HOMA-IR index. Insulin levels 
remained significant after adjusting for BMI. However, there was no interaction between time 
and type of diet for any of the variables. Negative results were shown in a study that 
compared the intervention with Mediterranean diet rich in omega 3 versus the standard 
Swedish diet (Ambring et al., 2004). Recently, results from PREDIMED study also reported 
that, after a median follow-up of 4 years, diabetes incidence was lower in the groups with 
Mediterranean diet as compared with control group (10,1% in Mediterranean diet with VOO, 
11% in Mediterranean diet with nuts, 17,9% in control group) (Salas-Salvado et al., 2011).  
In conclusion, overall adherence to Mediterranean diet is associated with lower FG levels as 
compared with the control diet (Kastorini et al., 2011). Among the mechanisms associated 
with that decrease in glucose levels are the properties of the components of Mediterranean 
diet. Fiber delays gastric emptying, antioxidants increase oxidative capacity and moderate 
alcohol could have a role in adiponectin. As a consequence, it ends in the prevention of 
insulin resistance and, finally, in prevention of type 2 diabetes (Schröder, 2007). 
3.4 Mediterranean diet and blood pressure 
Nutritional factors and dietary patterns have been associated with hypertension. 
Hypertensive individuals can remarkably reduce their blood pressure through nutritional 
changes. Mediterranean diet has also shown beneficial effects in the prevention and control 
of blood pressure. 
Cross-sectional studies associate the consumption of Mediterranean diet with lower systolic 
blood pressure (SBP). Higher adherence to Mediterranean diet was associated with lower 
SBP (p<0.001) (Tzima et al., 2007; Panagiotakos et al., 2006) as well as with 70% of decrease 
of prevalence of hypertension (Alvarez-León et al., 2006). In contrast, lower adherence was 
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associated with increased blood pressure (BP) (Pitsavos et al., 2007). However, one study 
showed higher SBP in the group more closely following the Mediterranean diet in the SUN 
cohort in young individuals after a median follow-up of 4.2 years (Nunez-Cordoba et al., 
2009). Most of the effects of the Mediterranean diet on blood pressure have been attributed 
to the consumption of olive oil, fruits, nuts and vegetables. Psaltopoulou et al (2004) in the 
Greek-EPIC cohort studied whether Mediterranean diet together or olive oil in particular 
reduced blood pressure in 20,343 people without a diagnosis of hypertension. In this study, 
the Mediterranean diet score was inversely and significantly associated with both, SBP and 
diastolic blood pressure (DBP), as well as the intake of olive oil, fruits and vegetables. 
However, Giuseppe et al (2008) found a significant and positive association of BP with the 
rate of adaptation to the Mediterranean diet. However, we have to consider that the study 
was carried out in older women (> 60 years). In the Italian EPIC Florence cohort, which 
include more than 10,000 non-hypertensive women aged 35-64 years, consumption of olive 
oil was inversely associated with DBP (Masala et al., 2008). However, with regard to DBP 
and Mediterranean diet as a whole, observational studies did not found significant 
associations (Kastorini et al., 2011).  
Regarding randomized clinical trials (level I scientific evidence) in a meta-analysis, it was 
found that the overall adherence to Mediterranean diet was associated with lower SBP and 
DBP as compared with control diet (Kastorini et al., 2011). In the PREDIMED study, results 
showed a significant decrease in both SBP and DBP in the two groups with Mediterranean 
diet (one supplemented with VOO and another with nuts) as compared with control group 
(Estruch et al., 2006). Finally, in a non-randomized clinical trial whose aim was to evaluate 
the effect of a moderately hypoenergetic Mediterranean diet with an exercise program in 
women with overweight-obesity, DBP decreased significantly (p <0.001) after two months of 
intervention, while the SBP was not changed significantly after four months of intervention 
(Andreoli et al., 2008).  
In conclusion, as we mention before, the beneficial effects of the Mediterranean diet on 
blood pressure have been attributed to a synergy of its components, especially to fruits, 
vegetables, nuts and olive oil. These components are low in sodium and rich in minerals 
(magnesium, potassium and calcium), antioxidant, fiber, PUFA and MUFA, all of them with 
potentially protective properties against hypertension.  
3.5 Mediterranean diet and inflammation 
Obesity and other related diseases associated with CVD are caused or related to 
inflammation. Three of five cross-sectional studies, showed a significant decrease in 
inflammation markers with higher adherence to Mediterranean diet (Sotos-Prieto et al., 
2010). Thus, Panagiotakos et al (2006) found significant negative association between 
adherence to Mediterranean diet and protein C reactive (CRP) (p <0.001). Also, the highest 
score in the AHEI index (Alternate Healthy Eating Index) and AMED (alternate 
mediterranean diet index) was associated with lower inflammation biomarkers 
concentrations (IL-6 and CRP) (24% and 16% respectively). This study was carried out in 690 
nurses, in the Nurses' Health Study (Fung et al., 2005). Moreover, subjects in the highest 
tertile of adherence to Mediterranean diet had 20 % lower CRP levels (p = 0.015) and 17% IL-
6 (p = 0.025) (Chrysohoou et al., 2004), while the lower adherence to Mediterranean diet was 
associated with higher levels of CRP (> 3.0 mg / ml) (Pitsavos et al., 2007). 
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Salas-Salvado et al (2008), in a study that included subjects with high cardiovascular risk 
(339H/433M, 55-80 years), found an association between consumption of certain foods that 
characterized the Mediterranean pattern (fruits, cereals, VOO and nuts) with lower 
concentrations of inflammatory markers, especially those related to endothelial function 
(ICAM-1 and VCAM-1). However, participants with higher adherence to a Mediterranean 
diet showed no significant decrease in the inflammatory biomarkers’ concentrations (CRP, 
IL-6, ICAM-1 and VCAM-1), although there was a statistical trend in the case of ICAM-1 
and VCAM-1 (p <0.1). 
In two randomized controlled trials, CRP levels decreased only in the group with 
Mediterranean diet supplemented with VOO (-0.54 mg / L) compared with the control 
group (low-fat). The IL-6 decreased in both groups with Mediterranean diet (VOO and 
nuts), whereas it increased in the group with low-fat diet. Similarly, Esposito et al (Esposito 
et al., 2004), in a study conducted in Italy with 180 people with metabolic syndrome (99H, 
81M), observed a significant decrease in CRP (p = 0.01) and IL-6 (p = 0.04) in the 
intervention group (instructed to follow a Mediterranean diet) compared with the control 
group (prudent diet with fat percentage <30%) after two years. By contrast, Michalsen et al 
(2006) found no changes in CRP levels, although there were some limitations in the study. 
In a non-randomized clinical trial, plasma levels of CRP decreased significantly (6%, P 
<0.02) after two hours of Mediterranean diet rich in MUFA intake (Blum et al., 2006).  
In conclusion, Mediterranean diet is characterized by a high consumption of fruit and 
vegetables. This adds other mechanistic benefits provided by their polyphenolic content to 
its high antioxidant content that could be linked with the prevention of inflammation. Other 
components of the Mediterranean diet such as VOO and red wine gather antioxidants and 
anti-inflammatory actions that may contribute to the healthy effects of this diet on 
inflammation.  
 
 
Decrease Increase No significant 
BMI (kg/m2) Scröder et al., 2004
Romaguera et al., 201 
Bes-Ballostro et al., 2009; Garcia-
Londa et al., 2003 
Martinez-Gonzalez & Bes-
Ballostro, 2011
  
Weight gain Fraser et al., 2002
Martinez-Gonzalez & Bes-
Ballostro, 2011
  
Waist 
circumference 
Romaguera et al., 2002
Martinez-Gonzalez & Bes-
Ballostro, 2011
  
TC Estruch et al.,2006
Vicent-Baudry et al., 2005 
Ambring et al., 2004
  
LDL-C Vicent-Baudry et al., 2005
Ambring et al., 2004 
Ros et al., 2004 
Andreoli et al., 2008 
 Michalsen et al., 
2006 
Goulet et al., 
2003 
Estruch et al., 
2006 
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Decrease Increase No significant 
HDL-C Pitsavos et al., 2007 Estruch et al, 2006 
Andreoli et al.,2008 
Papadaki & Scott, 2008 
Esposito  et al., 2004; 
Esposito et al., 2003; Esposito et 
al., 2009; Athryros et al., 2011 
Ambring et al., 2004 
Michalsen et al., 
2006 
Goulet et al., 
2003 
TG Estruch et al.,2006 
Vicent-Baudry et al., 2005 
Ambring et al., 2004 
Ros et al., 2004 
Chrysohoou et al., 2004;  
Tzima et al., 2007;  
Barzi et al., 2003 
Shai et al., 2008 
Esposito et al., 2004 
Esposito et al., 2009 
Elhayany et al., 2011 
Sabate et al., 2010 
 Michalsen et al., 
2006 
de Lorgeril et 
al., 1994 
Castro et al., 
2000 
Goulet et al., 
2003 
Glucose Estruch et al., 2006 
Vicent-Baudry et al., 2005 
Andreoli et al.,2008 
Panagiotakos et al., 2007 
Tzima et al., 2007 
Salas-Salvado et al., 2011 
 Ambring et al., 
2004 
SBP Estruch et al., 2006 
Tzima et al., 2007 
Psaltopoulou et al., 2004 
Panagiotakos et al., 2006 
Giussepe et al., 2008 
Nunez-Cordoba et al., 2009 
Andreoli et al., 
2008 
BP Estruch et al., 2006 
Andreoli et al., 2008 
Alvarez-Leon et al., 2006 
Psaltopoulou et al., 2004 
Pitsavos et al., 2007 
Masala et al., 2008 
  
CRP Estruch et al., 2006 
Esposito et al., 2004 
Blum et al., 2006 
Fung et al., 2005 
Chrysohoou et al., 2004 
Panagiotakos et al., 2006 
Pitsavos et al., 2007 Michalsen et al., 
2006 
Salas-Salvado et 
al., 2008 
IL-6 Estruch et al., 2006 
Esposito et al., 2004 
 Salas-Salvado et 
al., 2008 
BMI: Body mass index; TC: Total Cholesterol; LDL-C: Low density lipoprotein cholesterol 
HDL: High density lipoprotein cholesterol; TG: Triglycerides; SBP: Systolic blood pressure; BP: Blood 
pressure; CRP: Protein C reactive; IL-6: Interleukin 6 
Table 1. Studies that analyze Mediterranean diet and variation (decrease, increase, no 
significant) in intermediate cardiovascular disease phenotypes. 
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4. Nutritional genomics  
Current changes in lifestyle, in part promoted by the nutritional transition, have contributed 
to the development of CVD, cancer and other non-comunicable diseases. 
Since the Human Genome Project finished in April 2003, we have the information about the 
complete genome. However, we still unknown the role of the majority of genes involved in 
the development of CVD. For that reason, currently, considering diet as one of the most 
important environmental factor, the molecular nutrition begins with the approach to better 
understand the mechanism involved in the gene-diet interaction and to personalize the diet 
with the aim to prevent common diseases, among them, CVD. Since Human Genome Project 
finished, the classic candidate gene approach and the new genome-wide association studies 
have identified genetic variants that predispose people to CVD.  
In this sense, it was shown that human genome is sensitive to nutritional environment in 
two ways: nutrients may regulate genes and genes also influence the effect of diet 
(Loktionov, 2003). Nutritional health is dependent on the interaction between the 
environmental aspects of dietary components and the genetically controlled aspects (Figure 
1). The concept of gene-diet interaction describes the modulation of the effect of a dietary 
component on a specific phenotype (plasma lipid concentrations, obesity, etc.) by a genetic 
polymorphism (Ordovas & Corella, 2004). A better understanding of these interactions has 
the potential to support disease prevention and will lead to different requirements between 
individuals via modification of dietary recommendations. This research has led to the 
development of concepts that study the effect of genetic variation on the interaction between 
diet and specific phenotypes known as nutrigenetics. 
The goal of nutrigenetics is to generate personalized recommendations regarding the genetic 
susceptibility of each individual. It is also known as personalized nutrition.  
On the other hand, the study of the characterization of gene products and the physiological 
function and interactions of these products is known as nutrigenomics (Figure 1). The 
unifying term “nutritional genomics” refers to nutrigenomics and nutrigenetics (Ordovas & 
Corella, 2004). The term Nutrigenetics was named for the first time by Brennan in 1975 in his 
book “Nutrigenenetics: New concepts for Relieving Hypoglycemia”, while nutrigenomics 
was used in 1999 by DellaPenna when he studied the plant genomics field. The new 
technology research together with the knowledge of the human genome sequence have led 
in the study of the new “omics” to better understand the molecular basis of the disease 
development. They are the disciplines known as:  
- Transcriptomic: to quantify the level of gene expression by using techniques to analyse 
thousands of mRNA molecules at the same time by using a technique based on 
microarrays. 
- Proteomic: large-scale study of proteins (particularly their structure and function) is 
possible to identify proteins that can diagnose disease or predict the evolution of it. 
- Metabolomics: to study techniques dedicated to complete a system composed of a series 
of molecules that are metabolic intermediates, metabolites, hormones and other signal 
molecules, and secondary metabolites, which can be found in a biological system.  
- Systems Biology: integration of proteomic data, genetic, metabolomics.  
- Bioinformatics: to interpret the data to provide biological mechanisms to explain the 
experimental observations. 
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Following these new concepts, other related terms have emerged: nutritranscriptomic (the 
study of messenger RNA expression at the cellular level under some nutritional conditions),  
nutriproteomic (large-scale analysis of the structure and function of the protein, as well as 
protein-protein interactions in a cell to identify molecular targets of dietary components) or 
nutrimetabolomic (measuring all metabolites in response to stimuli nutritional body) 
(Panagiotou & Nielsen, 2009). 
LIFESTYLE
Olive oil
Vegetables
Fruits
Legumes
Fish, poultry, 
nuts
Red meat Low fat dairy products
OBESITY LIPID 
METABOLISM
INFLAMMATION BLOOD 
PRESSURE
DIABETES
PERSONALIZE NUTRITION
ADN
ARN
PROTEINS
METABOLITES
GENOTYPE
PHENOTYPE
NUTRIGENETICS
NUTRIGENOMICS
NUTRITRANSCRIPTOMICS
NUTRIPROTEOMICS
NUTRIMETABOLOMICS
Whole cereals
Daily 
consumption
Weekly 
consumption
Low 
consumption 
Interaction
MEDITERRANEAN DIET
 
Fig. 1. Personalized Nutrition.  As part of health determinants, lifestyle interacts with 
genetic susceptibility to modulate obesity risk, lipid metabolism, inflammation, blood 
pressure and diabetes.  Among lifestyle factors, diet, and especifically, Mediterrranean diet, 
has an important role in gen-diet interactions. On the other hand, with the new technology 
research together with the knowledge of  human genome sequence have led in the study of 
the nutrigenetics and nutrigenomics (nutritional genomics) to better understand the 
molecular basis of the disease development, they are the disciplines knows as: 
transcriptomic, proteomic, metabolomic that allow us to know phenotypes characteristics. 
These interactions between Mediterranean diet and genetic susceptibility will contribute to 
create personalized diets. 
5. Gene-Mediterranean diet interaction in intermediate cardiovascular 
diseases phenotypes 
In the following sections we are going to review some studies analyzing nutrigenetics and 
nutrigenomics effects on CVD. 
5.1 Nutrigenetics in the prevention of cardiovascular diseases 
In the last decades the eating pattern has changed considerably towards less healthy habits 
with excessive intake of calories and SFA. Considering this as a risk factor of CVD these 
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changes are contributing to the increase of CVD. As a result, researchers are wondering 
which could be the best diet to prevent CVD and related phenotypes. Different opinions 
have emerged about the virtues of low-carbohydrate diets, low fat diets, high-protein diets 
or Mediterranean dietary pattern in the control of body weight and factors related to CVD 
(Shai et al., 2008, Larsen et al., 2010, Sacks et al., 2009). 
Given the great diversity that exists with regard to dietary recommendations and their 
effects, several authors insist on the fact that there is no perfect diet. Diet will be different 
depending on individual characteristics. The response to the same diet has not the same 
effectiveness on different two people. While some people appear to have no response to 
dietary intervention (hiporesponders), others have a high response (hiperresponders) 
(Katan MB et al., 1986). It has been suggested that this inter-individual variability to dietary 
modification is determined by genetic factors, especially for phenotypes related to lipid 
metabolism (Loktionov, 2003). 
Most of the studies carried out to determine whether genetic factors could explain these 
differences are based on the study of single nucleotide polymorphisms (SNPs) as well as 
dietary factors, particularly those that characterize Mediterranean Diet. The table 2 shows 
some studies conducted to assess genetic modulations according to different types of diets 
or macronutrients. In the following paragraphs we describe the results from intervention 
studies and observational studies that analyze gene-diet interactions on CVD. 
Results from intervention studies  
Intervention studies in which subjects receive a controlled dietary intake provide the most 
valuable information for the study of gene-nutrient-phenotype association. However, 
intervention studies have some limitations, such as the low number of participants. The 
sample size is important in nutrigenetic studies because otherwise, there is a lack of statistical 
power to assess the main associations. Something similar happens with the study of some 
genetic variants. Prevalence of certain polymorphisms is small and requires a large sample size 
to study these associations. Another limitation is the short duration of these interventions. A 
review conducted by Masson et al, (2003) concluded that there is evidence to suggest that 
variations in the APOA1, APOA4, APOB and APOE genes contribute to the heterogeneity of 
the lipid response to dietary interventions, and that these genes are directly or indirectly 
regulated by PPAR or other nuclear receptors. New examples that confirm the importance of 
gene-diet interaction in the field of nutrigenetics are the study of the perilipin gene (PLIN) 
(Corella D et al., 2005, Smith CE et al., 2010) and SR-BI (Perez-Martinez P et al., 2005). 
Recently, some studies investigating the genetic modulation of the Mediterranean diet in 
PREDIMED study have been published. Thus, a study examining a polymorphism in the 
FTO gene (associated with obesity) shows that the A allele of the polymorphism rs9939609 
in the FTO gene was not associated with baseline body weight, but after 3 years of 
nutritional intervention with Mediterranean diet carriers of A allele had a lower body 
weight gain than subjects with the ancestral allele (Razquin C et al., 2010 A). 
Another example carried out in the PREDIMED study showed that CC subjects for the 
polymorphism-174G / C in the IL-6 gene had a lower weight gain after three years only in 
those subjects who followed a Mediterranean diet supplemented with nuts and olive oil 
(Razquin et al., 2010 B) 
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Results from observational studies 
Observational studies have the advantage of incorporating a large number of participants 
and the ability to estimate dietary habits. They also have the advantage that the distribution 
of genetic variants in the population is independent of eating behaviors by the principle of 
Mendelian randomization. Although nowadays the number of studies examining gene-diet 
interactions is increasing, few studies have investigated the interaction between SNPs in 
candidate genes and cardiovascular risk factors analyzing the consumption of 
Mediterranean diet or intake of MUFA, PUFA or SFA. 
One of the most studied genes has been the Pro12Ala polymorphism in the PPARG gene 
and its interaction with MUFA intake. Obese subjects with the Ala12 allele have higher 
HOMA index when they eat low amounts of MUFA. Another example analyzing MUFA 
intake and body weight depending on variation in APOA5 gene is one carried out in the 
Framingham study. They found a significant interaction between the promoter 
polymorphism -1131T>C in the APOA5 gene and fat intake, particularly MUFA, regulating 
body weight (Corella D et al., 2007). The study of C677T polymorphism in the gene for 
methylenetetrahydrofolate reductase (MTHFR) is another example of modulation of LDL 
oxidation by the Mediterranean diet (Pitsavos et al., 2006). Recently, we published a 
significant gene-diet interaction in a variant of the promoter of APOA2 gene. This study 
included 3462 volunteers from three different populations and it studied the interaction 
between the polymorphism-265T>C in the APOA2 gene, food intake, and BMI. Carriers of 
the variant allele which had higher intake of SFA had a higher prevalence of obesity while 
this was not showed if the source of fat was MUFA or PUFA. These results were replicated 
for the first time in three independent populations (Corella et al., 2009). Subsequently, the 
authors replicated this interaction in Mediterranean and Chinese populations (Corella et al., 
2011) confirming the importance of genetic modulation by dietary factors, and also the need 
to replicate gene-diet interactions to increase the scientific evidence and finally to contribute 
to personalize diet based on genetic susceptibility.  
 
Author Phenotype Gene Gen-diet interaction 
Lopez-
Miranda 
et al., 
1994 
L
ip
id
 m
et
ab
ol
is
m
 
LDL-C -75G>A APOA1 They studied the influence of the LDL-C 
postprandial response to MUFA intake. After 
high MUFA intake carriers of A allele had 
higher LDL-C but not the GG. 
Jansen et 
al., 1997 
LDL-C Thr347Ser APOA4 347Ser carriers had lower LDL-C postprandial 
response when they switched from a diet rich 
in SFA to a diet based on NCEP. 
Campos 
et al., 
2001 
VLDL, 
HDL-C 
APOE Higher VLDL and lower HDL-C in E2 with a 
high SFA intake.  
Corella 
et al., 
2001 
LDL-C APOE E2 carriers had lower LDL-C in those with 
moderate alcohol consumption than in non-
consumers. However, carriers of E4 allele that 
had a moderate alcohol consumption had 
higher LDL-C. 
Brown et 
al., 2003 
TC and 
LDL-C 
T455C y T625 APOC3 In -45T and -625T homozygous subjects, SFA 
intake was associated with higher LDL-C.  
Tai et al., 
2005 
TG and 
APOCIII 
L162V PPARA Carriers of 162V allele had higher TG 
concentrations and APOC3 levels only in that 
subjects with a low PUFA consumption. 
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Author Phenotype Gene Gen-diet interaction 
Robitaill
e et al., 
2007 
Lipids Leu72Met Grelina Interaction with fat intake modulating TG 
concentrations.  
Ordovas, 
2002 
HDL-C -514C>T LIPC T alelle was associated with higher HDL-C in 
subjects that had an intake of fat < 30% of total 
energy.  
Luan et 
al., 2001 
A
nt
ro
p
om
et
ri
c 
va
ri
ab
le
s 
BMI Pro12Ala PPARG AlaPPARG carriers had higher BMI than 
ProPPRG, but when the ratio PUFA:SFA was 
high, opposite results were shown.  
Memisog
lu et al., 
2003 
BMI Pro12Ala PPARG Among ProPro subjects, those with higher fat 
intake of had higher BMI compared to those 
with lower intake . No association was shown 
for 12Ala.  
Robitaill
e et al., 
2007 
 
WC Pro12Ala PPARA Interaction Pro12Ala with the intake of fat 
modulating waist circunference.  
Corella 
et al., 
2009 
BMI and 
Obesity  
-265 T>C 
APOA2 
C carriers that had high SFA intake had higher 
prevalence of obesity.  
Corella 
et al., 
2011 
BMI and 
obesity 
-265 T>C 
APOA2 
Interaction of -265CC with SFA intake 
modulating risk of obesity.  
Corella 
et al., 
2010  
BMI and 
obesity 
rs9939609 FTO Interacction of rs9939609 with educational 
level. A carriers had higher risk of obesity and 
BMI only in those without uneversity studies.  
Razquin 
et al., 
2010 (A) 
Weight rs9939609 FTO A allele was associated with higher weight at 
the beginnung of the study. After three years 
of intervention with Mediterranean diet, A 
carriers had a lower weight gain. 
Razquin 
et al., 
2010 (C) 
Weight +45T/G, +276G/T 
Adiponectin 
Genotype GG (+45T/G) was associated with 
higher weight gained during three years of 
intervention. TT (+276G/T) was associated 
with higher weight gain in men. 
Mediterranean diet suplemented with VOO 
and nuts reverted this effects.  
Razquin 
et al., 
2010 (B) 
Weight -174G/C  
IL-6 
CC subjects that followed Mediterranean diet 
suplemented with VOO had lower weight gain 
after three years of intervention.  
LDL-C: Low density lipoprotein cholesterol; VLDL: Very low density lipoprotein cholesterol 
HDL: High density lipoprotein cholesterol; TC: Total cholesterol; BMI: Body mass index 
WC: Waist circumference 
Table 2. Nutrigenetics studies analysing gene-diet interactions. 
5.2 Nutrigenomics in the prevention of cardiovascular diseases 
As we explained in the previous section, there is increasing evidence that Mediterranean 
diet, whose emblematic component is virgin olive oil (VOO), has a beneficial effect on 
diseases associated with CVD and other diseases (neurodegenerative diseases, cancer).  
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VOO is a functional food containing high levels of MUFA and a number of minor 
components (bioactive components). These components are known as phenolic compounds. 
These phenolic compounds have a key role in plasma lipid concentrations and oxidative 
damage (that is related to CVD). It is believed that the benefits from the consumption of 
VOO are due to the interaction of its nutrients and minor components with genes. Several 
studies have shown changes in gene expression mediated by the consumption of VOO. In 
table 3 some studies analyzing changes in gene expression of some genes related to CVD by 
Mediterranean diet or its components are shown.  
 
Autor N /duración Intervención Cambios de 
expresión 
Ruta implicada 
Konstantinidou 
 et al., 2010 
N=90 (20-50 years) 
3 months 
 
1. MD +VOO 
2. MD+ VOO  
3. Control 
INF-y
ARHGAP15 
IL7R 
ADRB2 
POLK
Inflammation 
 
 
Oxidative stress 
Konstantinidou  
et al., 2009 
N=6 
Postprandial study 
(0-6h) 
 
50 ml VOO 
(26082 genes)  
USP48
OGT 
AKAP13 
IL10 
DCLRE1C 
POLK
Cellular process 
Inflammation 
 
DNA damage 
Khymenets et 
al., 2009 
N= 6 H(262-28 years; 
4 M (20-44) 
3 weeks 
VOO (25 ml/day) ADAM17, 
ALDH1A, BIRC1, 
ERCC5, LIAS, 
OGT,PPARBP, 
TNFSF10, USP48, 
XRCC5 
Mechanism involved 
in atherosclerosis 
Camargo et al., 
2010 
N=20 with MS  
(56 years, 9 H, 11 M)
Postprandial state 
Breakfast with 
VOO (40 ml). 
 
EGR1 
IL1B, IL6 
CCL3 
CXCL1 
CXCL2 
CXCL3 
CXCR4  
TRIB1, NFKBIA 
Inflammation 
Llorente-Cortes  
et al., 2009 
N=48  (55-80 years) MD+VOO 
MD+nuts 
Control group 
COX-2 
LRP1 
MCP-1 
CD36 
TFPI 
Inflammation, foam 
cell formation, 
thrombosis 
De Mello VD  
et al., 2008 
34overweight MS 
33 weeks 
Weight reduction 
(n=24) 
Control group 
(n=10) 
TLR4 
TLR2 
CCL5 
TNFRSF1A 
IKBKB 
Related to insulin 
sensitivity 
Crujeiras et al., 
2008 
12 Obese  
(37,7 years) 
8 weeks 
Hypocaloric diet SIRT1 
SIRT2 
NDUFS2 
 
MD: Mediterranean diet; VOO: Virgin olive oil; MS: Metabolic Syndrome 
Table 3. Nutrigenomics studies  
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6. Conclusions and future directions  
Current results of the studies analyzing the effect of Mediterranean diet on CVD suggest 
that adherence to the Mediterranean dietary pattern was associated with lower CVD 
phenotypes. Mediterranean diet has a beneficial effect on abdominal obesity, lipids levels, 
glucose metabolism, blood pressure and inflammation. The antioxidant and anti-
inflammatory effects of the Mediterranean diet as a whole, and also the effects of the 
individual components, specifically VOO, fruits, vegetables, whole grains and fish could 
offer an explanation for the aforementioned beneficial effects of the Mediterranean diet. 
These results are of considerable public health importance because this dietary pattern can 
be easily adopted by all population groups and various cultures, and they cost effectively 
serve for the primary and secondary prevention of CVD. 
On the other hand, the current evidence from nutrigenetics studies is not enough to begin 
implementing specific personalized information. However, there is a large number of 
examples of common SNPs modulating the individual response to Mediterranean diet and 
other components as proof of concept of how gene-diet interactions can influence lipid 
metabolism, BMI, or other disorders, and it is expected that in the near future we will be 
able to harness the information contained in our genomes by using the behavioural tools to 
achieve successful personalized nutrition. In order to achieve that, it is recommended that 
future advises on nutrition will be based on studies using the highest level of 
epidemiological evidence and supported by mechanistic studies within the Nutritional 
Genomics and Systems biology. However, we have to take into account that in order to 
forget successful results in personalized nutrition through genetic variation, health 
professionals need to be prepared to learn and interpret genetic knowledge about their 
patients. 
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